Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

NCT07056595 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

IgA Nephropathy (IgAN)

Interventions

DRUG: Finerenone

Sponsor

Botkin Hospital